Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
June 21, 2021
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of June 20, 2021
B cell kinetics during HSV-2 infection
From the Corey lab, Vaccine and Infectious Disease Division
Comparing immune landscapes across respiratory infections
From the Lund and Prlic labs, Vaccine and Infectious Disease Division
Selective expression of granulysin in discrete menstrual phases
From the University of Washington and the Hladik lab, Vaccine and Infectious Disease Division
Immune signatures of severe COVID disease
From the Lund lab, Vaccine and Infectious Disease Division
Who should we vaccinate first?
From the Brown group, Vaccine and Infectious Disease Division, and the University of Washington
New study highlights lack of diversity and inclusion in vaccine clinical trials
Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed
Sequence diversity in cancer-causing viruses
From the Mullins lab, University of Washington and the Vaccine and Infectious Disease Division
Modeling the kinetics of an HIV cure
From the Schiffer group, Vaccine and Infectious Disease Division
BV-associated bacteria thrive in inflammatory environments
From the Fredricks Lab, Vaccine and Infectious Disease Division
Predicting SARS-CoV-2 antibody titers
From the Vaccine and Infectious Disease Division and the University of Washington
Seminal extracellular vesicles modulate ZIKV infection
From the Vojtech lab, Vaccine and Infectious Disease Division and the University of Washington Department of Obstetrics and Gynecology
Screening blood for a Zika virus vaccine
From the Koelle lab, University of Washington Department of Medicine and the Fred Hutch Vaccine and Infectious Disease Division
A SARS-CoV-2 testing pipeline for COVID-19 health care workers
From the University of Washington and the Fred Hutch Vaccine and Infectious Disease Division
Antibodies from infected patients are a template for a SARS-CoV-2 vaccine
From the McGuire, Pancera, and Stamatatos labs, Vaccine and Infectious Disease Division
Validating antibody tests to determine SARS-CoV-2 seroprevalence
From the University of Washington and the Jerome lab, Vaccine and Infectious Disease Division
Metagenomic sequencing uncovers SARS-CoV-2 co-infections
From the University of Washington and the Jerome lab, Vaccine and Infectious Disease Division
Targeted single-cell RNA sequencing maximizes cellular information at a lower cost
From the Gottardo, Newell, and Prlic labs, Vaccine and Infectious Disease Division
Antiviral cytokines pick up T cell slack
From the Schiffer group, Vaccine and Infectious Disease Division
Immune surveillance triggers HIV reactivation
From the Hladik lab, Vaccine and Infectious Disease Division
Genomic surveillance of the Colombian Zika virus outbreak
From the Bedford lab, Vaccine and Infectious Disease Division